Finally, we undertook a reanalysis of previously published human MMRd CRC patient data 17, with a particular emphasis on patients who had a complete responses or no response to anti-PD-1 therapy, while scrutinizing the underlying profiles of myeloid and T cells (Figure 3 E, Extended Figure 5). The gene discussed is PDCD1; the disease is colorectal carcinoma.